Istanbul, Ankara, and Antalya are Turkey's primary immunotherapy hubs, offering advanced treatments like checkpoint inhibitors and CAR-T therapy. Istanbul serves as the central medical capital, hosting JCI-accredited facilities like Anadolu Medical Center and Memorial Şişli, which follow international ESMO and NCCN oncology protocols.
- Istanbul leadership: Features the highest concentration of academic oncology centers and JCI-accredited hospitals.
- Ankara expertise: Functions as a research-intensive hub focusing on clinical trials and pediatric immunotherapy.
- Antalya accessibility: Combines multidisciplinary cancer care at Memorial Antalya with a Mediterranean recovery environment.
- Specialized techniques: Programs include Keytruda, Nivolumab, and CAR-T therapy for lung, breast, and melanoma.
Bookimed Expert Insight: Anadolu Medical Center in Istanbul stands out because of its direct affiliation with Johns Hopkins Medicine and multiple elite certifications, including OECI and IASIOS. While many Turkish clinics offer immunotherapy, this specific center serves 65,000 patients annually and maintains success rates like 81% for specific hematologic procedures. Choosing a facility with these western-partnered standards ensures your treatment protocol matches top-tier US or European hospital outcomes at significantly lower costs.
Patient Consensus: Patients value Istanbul clinics for having English-speaking oncologists and on-site PET scans, often noting that the care quality rivals major US centers. Some suggest sticking to major hubs like Istanbul to ensure consistent follow-up care and access to the latest drug generations.